Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy ; volume:15 ; number:1 ; day:10 ; month:8 ; year:2024 ; pages:1-10 ; date:12.2024
Nature Communications ; 15, Heft 1 (10.8.2024), 1-10, 12.2024
- Urheber
-
Ding, Haolun
Yuan, Min
Yang, Yaning
Xu, Xu Steven
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-51316-7
- URN
-
urn:nbn:de:101:1-2410292115410.380325292461
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ding, Haolun
- Yuan, Min
- Yang, Yaning
- Xu, Xu Steven
- SpringerLink (Online service)
Ähnliche Objekte (12)
Radiomics nomogram for predicting chemo-immunotherapy efficiency in advanced non-small cell lung cancer
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report
Histogram analysis of multiple diffusion models for predicting advanced non-small cell lung cancer response to chemoimmunotherapy
A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer
First-line management of metastatic non-small cell lung cancer: An Indian perspective
Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer
Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
Detection and characterization of circulating tumor cells in non-small cell lung cancer
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
Radiomics nomogram for predicting chemo-immunotherapy efficiency in advanced non-small cell lung cancer
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report
Histogram analysis of multiple diffusion models for predicting advanced non-small cell lung cancer response to chemoimmunotherapy
A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer
First-line management of metastatic non-small cell lung cancer: An Indian perspective
Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer
Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
Detection and characterization of circulating tumor cells in non-small cell lung cancer
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
Radiomics nomogram for predicting chemo-immunotherapy efficiency in advanced non-small cell lung cancer
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report
Histogram analysis of multiple diffusion models for predicting advanced non-small cell lung cancer response to chemoimmunotherapy
A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer
First-line management of metastatic non-small cell lung cancer: An Indian perspective
Time-dependent efficacy analysis of first-line immunotherapies for advanced non–small cell lung cancer
Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
Detection and characterization of circulating tumor cells in non-small cell lung cancer
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis